loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 22287 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 TAKEDA PHARMS USA (2)

filter

01 CAPSULE, DELAYED RELEASE;ORAL (2)

filter

01 RX (2)

filter

01 DEXILANT (2)

filter

01 Yes (2)

URL Supplier Web Content
CAPSULE, DELAYED R...
60MG
2009-01-30
22287
DEXILANT
RX
Yes
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CAPSULE, DELAYED R...
30MG
2009-01-30
22287
DEXILANT
RX
Yes
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 22287

Looking for FDA Orange Book APPLICATION 22287 2

19

Takeda Pharmaceutical, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is DEXLANSOPRAZOLE, with a corresponding application number 22287.

Regulatory Information RX

With a dosage strength 60MG

Dosage Form Route CAPSULE, DELAYED RELEASE; ORAL

Reference Listed Drug Yes

Approved since 2009-01-30

Therapeutic Equivalence (TE) Code AB

18

Takeda Pharmaceutical, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is DEXLANSOPRAZOLE, with a corresponding application number 22287.

Regulatory Information RX

With a dosage strength 30MG

Dosage Form Route CAPSULE, DELAYED RELEASE; ORAL

Reference Listed Drug Yes

Approved since 2009-01-30

Therapeutic Equivalence (TE) Code AB

Post Enquiry
POST ENQUIRY